Bill Snyder Archive — Page 84 of 121
-
July 5, 2016
Vanderbilt establishes innovation center to boost demographic representation in clinical trial enrollment
Many clinical trials are stopped prematurely because they fail to recruit enough study participants. Vanderbilt University Medical Center has received a five-year, $14 million grant from the National Center for Advancing Translational Sciences at the National Institutes of Health to address this. -
July 5, 2016
New NIH-funded center to study inefficiencies in clinical trials
Researchers at Vanderbilt University Medical Center and Duke Clinical Research Institute have received a major federal grant to study how multisite clinical trials of new drugs and therapies in children and adults can be conducted more rapidly and efficiently. -
June 24, 2016
Superior scan for tumors
Imaging with a compound that binds to neuroendocrine cells is a safer and more effective way to detect rare neuroendocrine tumors. -
June 23, 2016
It takes two to tango: beta cell development
Defining the genes required for the function of insulin-producing beta cells is crucial for ongoing efforts to develop a cell-based therapy for diabetes. -
June 23, 2016
Goldenring recognized for research mentorship efforts
James Goldenring, M.D., Ph.D., co-director of the Epithelial Biology Center at Vanderbilt University Medical Center (VUMC), has received a Research Mentor Award from the American Gastroenterology Association Institute Council for “outstanding research mentorship.” -
June 21, 2016
Vanderbilt and Human Vaccines Project launch initial studies to decode the human immune system
Researchers at Vanderbilt University Medical Center this month began recruiting volunteers to participate in a clinical trial aimed at decoding the human “immunome,” the genetic underpinnings of the immune system.